Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Oon

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 23, 2024
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort studyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Annals of the Rheumatic Diseases|February 29, 2024
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort studyYasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, et al.
Lupus Science & Medicine|July 8, 2025
Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohortRaychel Barallon, Kathryn Connelly, Vera Golder, et al.
The Lancet. Rheumatology|June 14, 2024
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Ning Li, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 23, 2024
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort studyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Annals of the Rheumatic Diseases|February 29, 2024
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort studyYasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, et al.
Lupus Science & Medicine|July 8, 2025
Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohortRaychel Barallon, Kathryn Connelly, Vera Golder, et al.
The Lancet. Rheumatology|June 14, 2024
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Ning Li, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Pageof 6